253 related articles for article (PubMed ID: 9343241)
1. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity.
Hoffman LR; Kuntz ID; White JM
J Virol; 1997 Nov; 71(11):8808-20. PubMed ID: 9343241
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones.
Bodian DL; Yamasaki RB; Buswell RL; Stearns JF; White JM; Kuntz ID
Biochemistry; 1993 Mar; 32(12):2967-78. PubMed ID: 8457561
[TBL] [Abstract][Full Text] [Related]
3. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion.
Russell RJ; Kerry PS; Stevens DJ; Steinhauer DA; Martin SR; Gamblin SJ; Skehel JJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17736-41. PubMed ID: 19004788
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel HA conformational change inhibitor of human influenza virus.
Yoshimoto J; Kakui M; Iwasaki H; Fujiwara T; Sugimoto H; Hattori N
Arch Virol; 1999; 144(5):865-78. PubMed ID: 10416371
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus.
Luo G; Torri A; Harte WE; Danetz S; Cianci C; Tiley L; Day S; Mullaney D; Yu KL; Ouellet C; Dextraze P; Meanwell N; Colonno R; Krystal M
J Virol; 1997 May; 71(5):4062-70. PubMed ID: 9094684
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
7. pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers.
Gray C; Tamm LK
Protein Sci; 1998 Nov; 7(11):2359-73. PubMed ID: 9828002
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin.
Zhu L; Li Y; Li S; Li H; Qiu Z; Lee C; Lu H; Lin X; Zhao R; Chen L; Wu JZ; Tang G; Yang W
PLoS One; 2011; 6(12):e29120. PubMed ID: 22195002
[TBL] [Abstract][Full Text] [Related]
9. Early steps of the conformational change of influenza virus hemagglutinin to a fusion active state: stability and energetics of the hemagglutinin.
Huang Q; Sivaramakrishna RP; Ludwig K; Korte T; Böttcher C; Herrmann A
Biochim Biophys Acta; 2003 Jul; 1614(1):3-13. PubMed ID: 12873761
[TBL] [Abstract][Full Text] [Related]
10. Exploring the early stages of the pH-induced conformational change of influenza hemagglutinin.
Zhou Y; Wu C; Zhao L; Huang N
Proteins; 2014 Oct; 82(10):2412-28. PubMed ID: 24854389
[TBL] [Abstract][Full Text] [Related]
11. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
[TBL] [Abstract][Full Text] [Related]
12. HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.
Hensen L; Matrosovich T; Roth K; Klenk HD; Matrosovich M
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597765
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.
Basu A; Komazin-Meredith G; McCarthy C; Antanasijevic A; Cardinale SC; Mishra RK; Barnard DL; Caffrey M; Rong L; Bowlin TL
ACS Infect Dis; 2017 May; 3(5):330-335. PubMed ID: 28301927
[TBL] [Abstract][Full Text] [Related]
14. Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change.
Doms RW; Helenius A; White J
J Biol Chem; 1985 Mar; 260(5):2973-81. PubMed ID: 3972812
[TBL] [Abstract][Full Text] [Related]
15. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
[TBL] [Abstract][Full Text] [Related]
16. Stabilization and Improvement of a Promising Influenza Antiviral: Making a PAIN PAINless.
Antanasijevic A; Hafeman NJ; Tundup S; Kingsley C; Mishra RK; Rong L; Manicassamy B; Wardrop D; Caffrey M
ACS Infect Dis; 2016 Sep; 2(9):608-615. PubMed ID: 27759373
[TBL] [Abstract][Full Text] [Related]
17. The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion.
Leikina E; LeDuc DL; Macosko JC; Epand R; Epand R; Shin YK; Chernomordik LV
Biochemistry; 2001 Jul; 40(28):8378-86. PubMed ID: 11444985
[TBL] [Abstract][Full Text] [Related]
18. An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
Li R; Song D; Zhu Z; Xu H; Liu S
PLoS One; 2012; 7(8):e41956. PubMed ID: 22876294
[TBL] [Abstract][Full Text] [Related]
19. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity.
Godley L; Pfeifer J; Steinhauer D; Ely B; Shaw G; Kaufmann R; Suchanek E; Pabo C; Skehel JJ; Wiley DC
Cell; 1992 Feb; 68(4):635-45. PubMed ID: 1739972
[TBL] [Abstract][Full Text] [Related]
20. Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
Cihan-Üstündağ G; Zopun M; Vanderlinden E; Ozkirimli E; Persoons L; Çapan G; Naesens L
Bioorg Med Chem; 2020 Jan; 28(1):115130. PubMed ID: 31753804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
